151 related articles for article (PubMed ID: 28027511)
41. Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report.
Raitasuo V; Lehtovaara R; Huttunen MO
Psychopharmacology (Berl); 1994 Sep; 116(1):115-6. PubMed ID: 7862923
[TBL] [Abstract][Full Text] [Related]
42. Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
Centorrino F; Albert MJ; Berry JM; Kelleher JP; Fellman V; Line G; Koukopoulos AE; Kidwell JE; Fogarty KV; Baldessarini RJ
Bipolar Disord; 2003 Oct; 5(5):370-4. PubMed ID: 14525559
[TBL] [Abstract][Full Text] [Related]
43. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
[TBL] [Abstract][Full Text] [Related]
44. Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports.
Ryu HU; Chung JY; Shin BS; Kang HG
BMC Neurol; 2020 Apr; 20(1):164. PubMed ID: 32354328
[TBL] [Abstract][Full Text] [Related]
45. Oxcarbazepine and hepatic porphyria.
Pierach CA
Epilepsia; 2002 Apr; 43(4):455; discussion 455. PubMed ID: 11952779
[No Abstract] [Full Text] [Related]
46. Does 'rebound mania' occur after stopping carbamazepine? A pilot study.
Macritchie KA; Hunt NJ
J Psychopharmacol; 2000; 14(3):266-8. PubMed ID: 11106306
[TBL] [Abstract][Full Text] [Related]
47. Oxcarbazepine in glossopharyngeal neuralgia: clinical response and effect on serum lipids.
Luef G; Poewe W
Neurology; 2004 Dec; 63(12):2447-8. PubMed ID: 15623731
[No Abstract] [Full Text] [Related]
48. Management of adverse effects of mood stabilizers.
Murru A; Popovic D; Pacchiarotti I; Hidalgo D; León-Caballero J; Vieta E
Curr Psychiatry Rep; 2015 Aug; 17(8):603. PubMed ID: 26084665
[TBL] [Abstract][Full Text] [Related]
49. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
50. Apparent complex partial seizures in a bipolar patient after withdrawal of carbamazepine.
Garbutt JC; Gillette GM
J Clin Psychiatry; 1988 Oct; 49(10):410-1. PubMed ID: 3170494
[TBL] [Abstract][Full Text] [Related]
51. Flying almost blind.
Leibenluft E
Am J Psychiatry; 2006 Jul; 163(7):1129-31. PubMed ID: 16816212
[No Abstract] [Full Text] [Related]
52. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
[TBL] [Abstract][Full Text] [Related]
53. Mania precipitated by carbamazepine withdrawal.
Scull DA; Trimble MR
Br J Psychiatry; 1995 Nov; 167(5):698. PubMed ID: 8564338
[No Abstract] [Full Text] [Related]
54. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
Barrons R; Roberts N
J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of oxcarbazepine in bipolar disorder.
Mazza M; Bria P; Mazza S
Can J Psychiatry; 2007 Apr; 52(4):272; author reply 272-3. PubMed ID: 17500309
[No Abstract] [Full Text] [Related]
56. [Use of antiepileptic drugs in bipolar disorder].
Pérez-Ceballos MA; Vega-Gil N; Sánchez MB; Armijo JA
Actas Esp Psiquiatr; 2006; 34(1):55-64. PubMed ID: 16525906
[TBL] [Abstract][Full Text] [Related]
57. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
[No Abstract] [Full Text] [Related]
58. Transient lesions of the splenium of the corpus callosum following rapid withdrawal of levetiracetam.
Sawagashira R; Narita H; Hashimoto N; Kurita T; Nakagawa S; Saitoh T; Kusumi I
Epileptic Disord; 2017 Sep; 19(3):379-382. PubMed ID: 28721933
[TBL] [Abstract][Full Text] [Related]
59. Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
Al-Edrus S; Norzaini R; Chua R; Puvanarajah S; Shuguna M; Muda S
Biomed Imaging Interv J; 2009 Oct; 5(4):e24. PubMed ID: 21610992
[TBL] [Abstract][Full Text] [Related]
60. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
Lu PL; Hodes JF; Zheng X; Hu XY
Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
